Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review

por Fresa, Alberto, Autore, Francesco, Galli, Eugenio, Tomasso, Annamaria, Stirparo, Luca, Innocenti, Idanna, Laurenti, Luca
Publicado 2021

PB1933: TREATMENT SEQUENCING AND OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED AT FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS: A THIRTY-YEAR SINGLE-CENTE...

por Fresa, Alberto, Autore, Francesco, Innocenti, Idanna, Tomasso, Annamaria, Iadevaia, Francesco, Stirparo, Luca, Mosca, Antonio, Benintende, Giulia, Galli, Eugenio, Giannarelli, Diana, Laurenti, Luca
Publicado 2023

VEGF and IL-6 Correlation in POEMS: a Potential Upcoming Marker of Active Disease and Early Autologous BMT Response

por Tomasso, Annamaria, Innocenti, Idanna, Autore, Francesco, Fresa, Alberto, Benintende, Giulia, Vuono, Florenzia, Baroni, Silvia, Giannotta, Claudia, Chiusolo, Patrizia, Sorà, Federica, Sica, Simona, Laurenti, Luca
Publicado 2022

Immune Response to Covid-19 Vaccination in Patients with Chronic Lymphocytic Leukaemia (CLL): An Experience from Two Italian Centres

por Innocenti, Idanna, Murru, Roberta, Benintende, Giulia, Galitzia, Andrea, Mosca, Antonio, Barabino, Luca, Stirparo, Luca, Tomasso, Annamaria, Fresa, Alberto, Autore, Francesco, Caocci, Giovanni, La Nasa, Giorgio, Laurenti, Luca
Publicado 2022

Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study

por Benintende, Giulia, Innocenti, Idanna, Fresa, Alberto, Autore, Francesco, Tomasso, Annamaria, Piciocchi, Alfonso, Vuono, Florenzia, Stirparo, Luca, Mosca, Antonio, Bacigalupo, Andrea, Gattei, Valter, Efremov, Dimitar, Sangiorgi, Eugenio, Laurenti, Luca
Publicado 2022

P1305: NEPA VERSUS ONDANSETRON FOR THE PREVENTION OF CINV IN PATIENTS WITH MULTIPLE MYELOMA OR LYMPHOMA UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION. A MONOCENTRIC REAL-LIFE...

por Innocenti, Idanna, Tomasso, Annamaria, Mosca, Antonio, Benintende, Giulia, Colalelli, Michela, Galli, Eugenio, Chiusolo, Patrizia, Metafuni, Elisabetta, Giammarco, Sabrina, Sorà, Federica, Assunta Limongiello, Maria, Fresa, Alberto, Stirparo, Luca, Lamberti, Fabio, Autore, Francesco, Bacigalupo, Andrea, Hohaus, Stefan, De Stefano, Valerio, Sica, Simona, Laurenti, Luca
Publicado 2023

Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study

por Fresa, Alberto, Autore, Francesco, Piciocchi, Alfonso, Catania, Gioacchino, Visentin, Andrea, Tomasso, Annamaria, Moretti, Marina, Vitale, Candida, Chiarenza, Annalisa, Morelli, Francesca, Sportoletti, Paolo, Marasca, Roberto, Sapienza, Giuseppe, Cuccaro, Annarosa, Murru, Roberta, Sanna, Alessandro, Patti, Caterina, Angeletti, Ilaria, Coscia, Marta, Trentin, Livio, Pietrasanta, Daniela, Innocenti, Idanna, Laurenti, Luca
Publicado 2022

CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia

por D’Arena, Giovanni, Vitale, Candida, Coscia, Marta, Lamorte, Daniela, Pietrantuono, Giuseppe, Perutelli, Francesca, D’Auria, Fiorella, Statuto, Teodora, Valvano, Luciana, Tomasso, Annamaria, Griggio, Valentina, Jones, Rebecca, Mansueto, Giovanna, Villani, Oreste, D’Agostino, Simona, Viglioglia, Vito, De Feo, Vincenzo, Calapai, Fabrizio, Mannucci, Carmen, Sgambato, Alessandro, Efremov, Dimitar G., Laurenti, Luca
Publicado 2021

PB1942: PARTIAL RESPONSE WITH LYMPHOCYTOSIS (PR-L) IS NOT APPLICABLE FOR ACALABRUTINIB. AN ITALIAN MULTICENTER EXPERIENCE OF REAL LIFE.

por Innocenti, Idanna, Mosca, Antonio, Tomasso, Annamaria, Galitzia, Andrea, Scarfò, Lydia, Galli, Eugenio, Laureana, Roberta, Benintende, Giulia, Mattiello, Veronica, Morelli, Francesca, Chiriu, Sabrina, Del Principe, Maria Ilaria, Zamprogna, Giulia, Gentile, Massimo, Fabbri, Nicole, Autore, Francesco, Sportoletti, Paolo, Fresa, Alberto, Catania, Gioacchino, Coscia, Marta, Tedeschi, Alessandra, Sanna, Alessandro, Varettoni, Marzia, Ghia, Paolo, Murru, Roberta, Laurenti, Luca
Publicado 2023

Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study

por Innocenti, Idanna, Reda, Gianluigi, Visentin, Andrea, Coscia, Marta, Motta, Marina, Murru, Roberta, Moia, Riccardo, Gentile, Massimo, Pennese, Elsa, Quaglia, Francesca Maria, Albano, Francesco, Cassin, Ramona, Deodato, Marina, Ielo, Claudia, Frustaci, Anna Maria, Piciocchi, Alfonso, Rughini, Arianna, Arena, Valentina, Di Sevo, Daniela, Tomasso, Annamaria, Autore, Francesco, Del Poeta, Giovanni, Scarfò, Lydia, Mauro, Francesca Romana, Tedeschi, Alessandra, Trentin, Livio, Pompili, Maurizio, Foà, Robin, Ghia, Paolo, Cuneo, Antonio, Laurenti, Luca
Publicado 2022